buckwheat sprouts / HO-1 Cancer Research Results

BuckWS, buckwheat sprouts: Click to Expand ⟱
Features:

Buckwheat Sprouts — edible young seedlings produced by germination of buckwheat, principally common buckwheat (Fagopyrum esculentum) and Tartary buckwheat (Fagopyrum tataricum). They are a flavonoid- and polyphenol-rich functional food rather than a standardized drug or single-molecule therapeutic. Common buckwheat sprouts characteristically contain rutin, orientin, isoorientin, vitexin, isovitexin, quercetin-related glycosides, chlorogenic acid and other phenolic compounds, whereas Tartary buckwheat sprouts are generally more rutin-dominant and can contain substantially higher rutin concentrations. Germination markedly alters the phytochemical profile relative to ungerminated grain. Composition varies with species, sprouting duration, illumination, cultivar and cultivation conditions. Buckwheat sprouts also contain the phototoxic naphthodianthrone derivatives fagopyrins, making excessive consumption of green sprouts potentially more problematic than consumption of buckwheat grain.

Primary mechanisms (ranked):

  1. Polyphenol/flavonoid-mediated redox modulation, including direct radical scavenging, inhibition of lipid oxidation and enhancement of endogenous antioxidant defenses.
  2. Suppression of inflammatory NF-κB/MAPK signaling with reduced iNOS, COX-2, TNF-α, IL-6 and related inflammatory mediators.
  3. NRF2/KEAP1 antioxidant-response activation, demonstrated particularly with Tartary buckwheat sprout polyphenol extracts, increasing HO-1, NQO1, SOD, CAT and GST.
  4. Metabolic and vascular modulation attributable to rutin, flavonoids, GABA and other sprout constituents, including effects on lipid metabolism and, particularly after fermentation, ACE-related blood-pressure regulation.
  5. Potential antiproliferative and cytotoxic effects of concentrated buckwheat polyphenol preparations in cancer-cell models; direct anticancer evidence for ordinary dietary buckwheat sprouts remains substantially weaker than evidence for isolated constituent flavonoids or concentrated extracts.

Bioavailability / PK relevance: Buckwheat sprouts are a complex food matrix and do not have a single definable pharmacokinetic profile. Rutin has relatively poor absorption as intact rutin and largely reaches the colon, where microbial metabolism produces quercetin and other metabolites that subsequently enter the circulation. Human pharmacokinetic studies demonstrate delayed and highly variable systemic exposure after rutin-containing foods. The C-glycosyl flavones orientin, isoorientin, vitexin and isovitexin contribute additional exposure but their concentrations vary substantially among sprout preparations. Consequently, phytochemical content cannot be directly converted into systemic therapeutic exposure.

In-vitro vs systemic exposure relevance: Concentrated methanolic, ethanolic, polyphenol-rich or subcritical-water sprout extracts used in many cell studies can produce concentrations substantially different from those achievable by eating ordinary fresh sprouts. Cancer-cell and mechanistic extract studies should therefore not be interpreted as demonstrating equivalent systemic anticancer activity from dietary consumption. Food-level effects are more plausibly mediated by repeated intestinal exposure, metabolites and modulation of antioxidant, inflammatory and metabolic pathways.

Clinical evidence status: Predominantly preclinical and nutritional. Evidence includes compositional studies, biochemical assays, cultured-cell studies and animal models of inflammation, oxidative stress, dyslipidemia and hypertension. Direct randomized human therapeutic trials of buckwheat sprouts themselves are sparse or absent in the literature identified, and there is no established clinical anticancer indication. Buckwheat sprouts should therefore be classified as a functional food / preclinical nutraceutical rather than an established treatment. Safety is generally compatible with food use, but large or repetitive consumption of green sprouts may increase fagopyrin exposure and risk of photosensitization; one experimental assessment proposed keeping fresh sprout intake below approximately 40 g/day, although a validated human toxicological threshold has not been established.

Major Bioactive Ingredients in Buckwheat Sprouts

Ingredient Class Relative Importance Peak Sprout Age Content at Peak Notes
Isoorientin C-glycosyl flavone Major Day 3(debatable) 5.8 mg/100 g fresh weight Peaks early during sprout development and subsequently declines. One of the characteristic luteolin C-glycosides of common buckwheat sprouts.
Orientin C-glycosyl flavone Major Day 3(debatable) 11.7 mg/100 g fresh weight Peaks early during sprout development and subsequently declines. Characteristic luteolin C-glycoside.
Isovitexin C-glycosyl flavone Major Day 3(debatable) 26.2 mg/100 g fresh weight One of the most abundant C-glycosyl flavones in young common buckwheat sprouts. Concentration declines as sprouts mature.
Vitexin C-glycosyl flavone Major Day 3(debatable) 28.9 mg/100 g fresh weight Highest of the four measured C-glycosyl flavones at day 3 in the referenced growth study. Declines substantially by day 10.
Rutin Flavonol glycoside Major Day 6 109.0 mg/100 g fresh weight Unlike the C-glycosyl flavones, rutin continues increasing after day 3 and reaches a pronounced fresh-weight maximum around day 6 before declining. Especially abundant in Tartary buckwheat.
Quercetin-3-O-robinobioside Flavonol glycoside Major to moderate Not clearly established Variable Characteristic flavonol glycoside of common buckwheat sprouts. Available studies confirm its presence but do not establish a consistent developmental peak comparable with the five major phenols above.
Quercetin Flavonol Moderate Species-dependent Variable More prominent in some Tartary buckwheat preparations. Germination-time behavior differs by cultivar and species, so a single optimal harvest day should not be assigned.
Chlorogenic acid Phenolic acid Moderate Not clearly established Variable Important non-flavonoid phenolic constituent, but a reproducible peak harvest age is not sufficiently established.

Harvest interpretation: Approximately day 3 favors maximum concentrations of the C-glycosyl flavones isoorientin, orientin, isovitexin and vitexin. Approximately day 6 provides a better overall compromise because rutin and total measured phenols peak at this stage. In one common buckwheat study, total phenols reached 162.9 mg/100 g fresh weight at day 6.
-in common buckwheat, orientin, isoorientin, vitexin, and isovitexin are reported at their highest concentrations in the cotyledons.
-***other study claims "In the edible parts of common buckwheat sprouts, individual phenolics significantly increased during sprout growth from 6 to 10 days after sowing (DAS), whereas in tartary buckwheat sprouts they did not." ****

Tartary Buckwheat Sprout Flour Compared with Fresh Sprouts

Form Rutin Potential Other Flavonoids Main Advantages Main Limitations Overall Interpretation
Fresh Tartary buckwheat sprouts High; commonly about 20–50+ mg/g dry weight Present, but rutin is usually dominant Least processed; retains fresh plant matrix; no drying-related degradation High water content; perishable; larger serving required for equivalent dry-matter intake Excellent whole-food source, especially for rutin
Tartary buckwheat sprout flour or powder High; approximately 20–50+ mg/g powder may be achievable depending on cultivar and processing Retained to varying degrees depending on drying method Concentrated; shelf-stable; easy to measure and consume; substantially less volume than fresh sprouts Processing can reduce flavonoids; quality depends strongly on drying temperature and storage Potentially nearly as useful as fresh sprouts for rutin if gently dried
Freeze-dried Tartary buckwheat sprout powder Very high retention expected Generally better preserved than with high-temperature drying Excellent phytochemical preservation; concentrated and stable More expensive; product availability may be limited Preferred dried formulation when maximum flavonoid retention is the objective
Hot-air-dried Tartary buckwheat sprout flour High if dried under controlled moderate temperatures Moderate to high retention Lower cost than freeze drying; practical for commercial production Heat can reduce rutin and other phenolics; retention depends on temperature and duration Good option when drying is performed at approximately 50–70°C rather than high baking temperatures
Tartary buckwheat grain flour Moderate; commonly much lower than sprout flour Different profile from sprouted material Cheap; widely available; easy to incorporate into foods Not equivalent to sprout flour; substantially lower rutin in many comparisons Useful food ingredient but inferior to true sprout flour for concentrated rutin delivery
Common buckwheat sprouts or microgreens Lower than Tartary buckwheat Richer balanced mixture of orientin, isoorientin, vitexin and isovitexin Broader flavonoid profile; useful complement to Tartary buckwheat Lower rutin concentration Potentially preferable when the objective is broad C-glycosyl flavone exposure rather than maximum rutin

Practical interpretation: Tartary buckwheat sprout flour is a concentrated and convenient alternative to fresh sprouts, particularly when rutin is the primary target. Freeze-dried or gently dried sprout powder is preferable because excessive heat can reduce flavonoid content. Sprout flour should not be confused with ordinary Tartary buckwheat grain flour, which generally contains substantially less rutin.

Buckwheat Sprout Mechanisms

Rank Pathway / Axis Cancer Cells Normal Cells Primary Effect Notes / Interpretation
1 Oxidative stress and antioxidant defense ROS ↓ (context-dependent) ROS ↓; antioxidant capacity ↑ Redox protection Sprout extracts scavenge radicals, inhibit lipid oxidation and reduce intracellular peroxide and superoxide. Unlike many cytotoxic anticancer agents, the dominant sprout-level evidence is antioxidant rather than pro-oxidant.
2 NF-κB inflammatory signaling NF-κB ↓ NF-κB ↓ Anti-inflammatory signaling Buckwheat sprout extracts inhibit NF-κB p65 nuclear translocation and inflammatory mediator production in macrophage and inflammatory models.
3 NRF2 KEAP1 antioxidant response NRF2 ↑ NRF2 ↑ (model-dependent) Induction of endogenous antioxidant enzymes Tartary buckwheat sprout polyphenol extract promoted NRF2 nuclear translocation with HO-1, NQO1, SOD, CAT and GST induction in oxidatively stressed HepG2 cells.
4 COX-2 and iNOS inflammatory mediators COX-2 ↓; iNOS ↓ COX-2 ↓; iNOS ↓ Reduced inflammatory mediator synthesis Observed principally in LPS-stimulated macrophage/extract models.
5 Pro-inflammatory cytokines IL-6 ↓; TNF-α ↓ IL-6 ↓; TNF-α ↓ Anti-inflammatory effect Supported by macrophage studies and oral administration of sprout extract in inflammatory mouse models.
6 MAPK inflammatory signaling MAPK phosphorylation ↓ MAPK phosphorylation ↓ Inflammatory signal suppression Especially documented for flavonoid-rich Tartary buckwheat sprout preparations.
7 Mitochondrial redox homeostasis Mitochondrial membrane potential normalization Mitochondrial protection (model-dependent) Protection against oxidative mitochondrial dysfunction Demonstrated in H2O2-stressed HepG2 cells; this is cytoprotective rather than evidence of selective cancer-cell mitochondrial toxicity.
8 Lipid metabolism Not established Triglycerides ↓ (animal models) Metabolic modulation Sprout preparations have improved selected lipid endpoints in animal studies, but findings depend strongly on sprout processing and diet model.
9 ACE and vascular signaling Not established ACE ↓; vasorelaxation ↑ Potential blood-pressure reduction Strongest evidence applies to fermented buckwheat sprouts and fermentation-derived peptides rather than ordinary fresh sprouts.
10 Cancer cell proliferation and viability Viability ↓ (high concentration only) Not established Potential cytotoxicity Reported mainly for concentrated polyphenol extracts. Ordinary dietary sprout intake has not been shown to achieve comparable systemic exposure.
11 Clinical Translation Constraint Dietary exposure far below many extract-study conditions Variable phytochemical exposure Limits therapeutic extrapolation Species, sprouting age, lighting and extraction strongly alter flavonoid content. Rutin has low and delayed oral bioavailability. Fagopyrin exposure and potential phototoxicity limit indiscriminate high-dose green-sprout consumption.


HO-1, HMOX1: Click to Expand ⟱
Source:
Type:
(Also known as Hsp32 and HMOX1)
HO-1 is the common abbreviation for the protein (heme oxygenase‑1) produced by the HMOX1 gene.
HO-1 is an enzyme that plays a crucial role in various cellular processes, including the breakdown of heme, a toxic molecule. Research has shown that HO-1 is involved in the development and progression of cancer.
-widely regarded as having antioxidant and cytoprotective effects
-The overall activity of HO‑1 helps to reduce the pro‐oxidant load (by degrading free heme, a pro‑oxidant) and to generate molecules (like bilirubin) that can protect cells from oxidative damage

Studies have found that HO-1 is overexpressed in various types of cancer, including lung, breast, colon, and prostate cancer. The overexpression of HO-1 in cancer cells can contribute to their survival and proliferation by:
  Reducing oxidative stress and inflammation
  Promoting angiogenesis (the formation of new blood vessels)
  Inhibiting apoptosis (programmed cell death)
  Enhancing cell migration and invasion
When HO-1 is at a normal level, it mainly exerts an antioxidant effect, and when it is excessively elevated, it causes an accumulation of iron ions.

A proper cellular level of HMOX1 plays an antioxidative function to protect cells from ROS toxicity. However, its overexpression has pro-oxidant effects to induce ferroptosis of cells, which is dependent on intracellular iron accumulation and increased ROS content upon excessive activation of HMOX1.

-Curcumin   Activates the Nrf2 pathway leading to HO‑1 induction; known for its anti‑inflammatory and antioxidant effects.
-Resveratrol  Induces HO‑1 via activation of SIRT1/Nrf2 signaling; exhibits antioxidant and cardioprotective properties.
-Quercetin   Activates Nrf2 and related antioxidant pathways; contributes to anti‑oxidative and anti‑inflammatory responses.
-EGCG     Promotes HO‑1 expression through activation of the Nrf2/ARE pathway; also exhibits anti‑inflammatory and anticancer properties.
-Sulforaphane One of the most potent natural HO‑1 inducers; triggers Nrf2 nuclear translocation and upregulates a battery of phase II detoxifying enzymes.
-Luteolin    Induces HO‑1 via Nrf2 activation; may also exert anti‑inflammatory and neuroprotective effects in various cell models.
-Apigenin   Has been reported to induce HO‑1 expression partly via the MAPK and Nrf2 pathways; also known for anti‑inflammatory and anticancer activities.
Scientific Papers found: Click to Expand⟱
7944- BuckWS,    Extracts from Tartary Buckwheat Sprouts Restricts Oxidative Injury Induced by Hydrogen Peroxide in HepG2 by Upregulating the Redox System
- in-vitro, Nor, HepG2
*ROS↓, *MMP↑, *TAC↑, *SOD↑, *Catalase↑, *GSTA1↑, *NRF2↑, *NQO1↑, *HO-1↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

Catalase↑, 1,   GSTA1↑, 1,   HO-1↑, 1,   NQO1↑, 1,   NRF2↑, 1,   ROS↓, 1,   SOD↑, 1,   TAC↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

MMP↑, 1,  
Total Targets: 9

Scientific Paper Hit Count for: HO-1, HMOX1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:470  Target#:597  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page